The candidate IL-6 inhibitors currently undergoing clinical trials include sarilumab, ALX-0061, MEDI5117, clazakizumab, and olokizumab
As part of the antioxidant defence system, GSH participates in conjugation reactions catalyzed by glutathione-S-transferases (GSTs), in the reduction of hydrogen peroxide (H O ) and lipid hydroperoxides (LOOH) catalyzed by glutathione peroxidases (Gpxs), and the reduction 2 2 of protein-disulfi des (PrSSG) catalyzed by glutaredoxins (Grxs)
Voor medisch gebruik of toepassingen dient u zich te wenden tot een gekwalificeerde professional.
Rapid evolution by positive Darwinian selection in T-cell antigen CD4 in primates
In tendon and ligament research, BPC-157 stimulates collagen synthesis through tendon-derived fibroblast activity and counteracts the anti-healing effects that NSAIDs and corticosteroids can impose on connective tissue, which is clinically relevant for patients who have used these medications prior to starting a peptide protocol
